Correction to “Leveraging QSP Models for MIPD: A Case Study for Warfarin/INR”

IF 6.3 2区医学 Q1 PHARMACOLOGY & PHARMACY

Clinical Pharmacology & Therapeutics Pub Date : 2024-12-12 DOI:10.1002/cpt.3517

引用次数: 0

Abstract

Falkenhagen, U., Cavallari, L.H., Duarte, J.D., Kloft, C., Schmidt, S. and Huisinga, W. (2024), Leveraging QSP models for MIPD: a case study for Warfarin/INR. Clin Pharmacol Ther, 116: 795–806. https://doi.org/10.1002/cpt.3274.

In the published version of the above article, the authors noticed that one of the funding details was missing and it has been listed below.

“The research of WH has been partially funded by the Deutsche Forschungsgemeinschaft (DFG) – Project-ID 318763901 – SFB1294.”

We apologize for this error.

查看原文本刊更多论文

更正“利用QSP模型进行MIPD：华法林/印度卢比的案例研究”。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Pharmacology & Therapeutics 医学-药学

CiteScore

12.70

自引率

7.50%

发文量

290

审稿时长

2 months

期刊介绍： Clinical Pharmacology & Therapeutics (CPT) is the authoritative cross-disciplinary journal in experimental and clinical medicine devoted to publishing advances in the nature, action, efficacy, and evaluation of therapeutics. CPT welcomes original Articles in the emerging areas of translational, predictive and personalized medicine; new therapeutic modalities including gene and cell therapies; pharmacogenomics, proteomics and metabolomics; bioinformation and applied systems biology complementing areas of pharmacokinetics and pharmacodynamics, human investigation and clinical trials, pharmacovigilence, pharmacoepidemiology, pharmacometrics, and population pharmacology.